Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Sinopharm Files for China Approval of COVID-19 Vaccine, Bloomberg Says

Week in Review: BeiGene Plans $2.5 Billion IPO on Shanghai Star Exchange

Exclusive Interview: LianBio and Pfizer Create a First-in-Kind Collaboration in Greater China

Week in Review: RemeGen, a Yantai Biologics Company, Completes $515 Million Hong Kong IPO

Exclusive: Decheng's Inside View of Merck's $2.75 Billion Acquisition of VelosBio

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020